257 related articles for article (PubMed ID: 18292294)
1. Structural requirements for activation of the 5-oxo-6E,8Z, 11Z,14Z-eicosatetraenoic acid (5-oxo-ETE) receptor: identification of a mead acid metabolite with potent agonist activity.
Patel P; Cossette C; Anumolu JR; Gravel S; Lesimple A; Mamer OA; Rokach J; Powell WS
J Pharmacol Exp Ther; 2008 May; 325(2):698-707. PubMed ID: 18292294
[TBL] [Abstract][Full Text] [Related]
2. The eosinophil chemoattractant 5-oxo-ETE and the OXE receptor.
Powell WS; Rokach J
Prog Lipid Res; 2013 Oct; 52(4):651-65. PubMed ID: 24056189
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and biologic effects of 5-oxoeicosanoids on human neutrophils.
Powell WS; MacLeod RJ; Gravel S; Gravelle F; Bhakar A
J Immunol; 1996 Jan; 156(1):336-42. PubMed ID: 8598482
[TBL] [Abstract][Full Text] [Related]
4. 5-Oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of human eosinophil migration.
Powell WS; Chung D; Gravel S
J Immunol; 1995 Apr; 154(8):4123-32. PubMed ID: 7706749
[TBL] [Abstract][Full Text] [Related]
5. TG1019/OXE, a Galpha(i/o)-protein-coupled receptor, mediates 5-oxo-eicosatetraenoic acid-induced chemotaxis.
Hosoi T; Sugikawa E; Chikada A; Koguchi Y; Ohnuki T
Biochem Biophys Res Commun; 2005 Sep; 334(4):987-95. PubMed ID: 16039985
[TBL] [Abstract][Full Text] [Related]
6. 5-Lipoxygenase products regulate basophil functions: 5-Oxo-ETE elicits migration, and leukotriene B(4) induces degranulation.
Iikura M; Suzukawa M; Yamaguchi M; Sekiya T; Komiya A; Yoshimura-Uchiyama C; Nagase H; Matsushima K; Yamamoto K; Hirai K
J Allergy Clin Immunol; 2005 Sep; 116(3):578-85. PubMed ID: 16159627
[TBL] [Abstract][Full Text] [Related]
7. Effects of 5-oxo-6,8,11,14-eicosatetraenoic acid on expression of CD11b, actin polymerization, and adherence in human neutrophils.
Powell WS; Gravel S; Halwani F; Hii CS; Huang ZH; Tan AM; Ferrante A
J Immunol; 1997 Sep; 159(6):2952-9. PubMed ID: 9300719
[TBL] [Abstract][Full Text] [Related]
8. The OXE receptor: a new therapeutic approach for asthma?
Jones CE
Trends Mol Med; 2005 Jun; 11(6):266-70. PubMed ID: 15949767
[TBL] [Abstract][Full Text] [Related]
9. A biased non-Gαi OXE-R antagonist demonstrates that Gαi protein subunit is not directly involved in neutrophil, eosinophil, and monocyte activation by 5-oxo-ETE.
Konya V; Blättermann S; Jandl K; Platzer W; Ottersbach PA; Marsche G; Gütschow M; Kostenis E; Heinemann A
J Immunol; 2014 May; 192(10):4774-82. PubMed ID: 24733850
[TBL] [Abstract][Full Text] [Related]
10. Expression and characterization of a 5-oxo-6E,8Z,11Z,14Z-eicosatetraenoic acid receptor highly expressed on human eosinophils and neutrophils.
Jones CE; Holden S; Tenaillon L; Bhatia U; Seuwen K; Tranter P; Turner J; Kettle R; Bouhelal R; Charlton S; Nirmala NR; Jarai G; Finan P
Mol Pharmacol; 2003 Mar; 63(3):471-7. PubMed ID: 12606753
[TBL] [Abstract][Full Text] [Related]
11. Biosynthesis and actions of 5-oxoeicosatetraenoic acid (5-oxo-ETE) on feline granulocytes.
Cossette C; Gravel S; Reddy CN; Gore V; Chourey S; Ye Q; Snyder NW; Mesaros CA; Blair IA; Lavoie JP; Reinero CR; Rokach J; Powell WS
Biochem Pharmacol; 2015 Aug; 96(3):247-55. PubMed ID: 26032638
[TBL] [Abstract][Full Text] [Related]
12. LTA(4)-derived 5-oxo-eicosatetraenoic acid: pH-dependent formation and interaction with the LTB(4) receptor of human polymorphonuclear leukocytes.
Falgueyret J; Riendeau D
Biochim Biophys Acta; 2000 Feb; 1484(1):51-8. PubMed ID: 10685030
[TBL] [Abstract][Full Text] [Related]
13. 5-oxo-6,8,11,14-eicosatetraenoic acid is a potent stimulator of L-selectin shedding, surface expression of CD11b, actin polymerization, and calcium mobilization in human eosinophils.
Powell WS; Gravel S; Halwani F
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):163-70. PubMed ID: 9870930
[TBL] [Abstract][Full Text] [Related]
14. Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE.
Powell WS; Rokach J
Prog Lipid Res; 2005; 44(2-3):154-83. PubMed ID: 15893379
[TBL] [Abstract][Full Text] [Related]
15. Substrate selectivity of 5-hydroxyeicosanoid dehydrogenase and its inhibition by 5-hydroxy-Delta6-long-chain fatty acids.
Patel P; Cossette C; Anumolu JR; Erlemann KR; Grant GE; Rokach J; Powell WS
J Pharmacol Exp Ther; 2009 Apr; 329(1):335-41. PubMed ID: 19164464
[TBL] [Abstract][Full Text] [Related]
16. Targeting the OXE receptor as a potential novel therapy for asthma.
Powell WS; Rokach J
Biochem Pharmacol; 2020 Sep; 179():113930. PubMed ID: 32240653
[TBL] [Abstract][Full Text] [Related]
17. Eotaxin and RANTES enhance 5-oxo-6,8,11,14-eicosatetraenoic acid-induced eosinophil chemotaxis.
Powell WS; Ahmed S; Gravel S; Rokach J
J Allergy Clin Immunol; 2001 Feb; 107(2):272-8. PubMed ID: 11174193
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of 5-oxo-6,8,11,14-eicosatetraenoic acid-induced activation of neutrophils and eosinophils by novel indole OXE receptor antagonists.
Gore V; Gravel S; Cossette C; Patel P; Chourey S; Ye Q; Rokach J; Powell WS
J Med Chem; 2014 Jan; 57(2):364-77. PubMed ID: 24351031
[TBL] [Abstract][Full Text] [Related]
19. Human neutrophils convert the sebum-derived polyunsaturated fatty acid Sebaleic acid to a potent granulocyte chemoattractant.
Cossette C; Patel P; Anumolu JR; Sivendran S; Lee GJ; Gravel S; Graham FD; Lesimple A; Mamer OA; Rokach J; Powell WS
J Biol Chem; 2008 Apr; 283(17):11234-43. PubMed ID: 18287092
[TBL] [Abstract][Full Text] [Related]
20. Novel highly potent OXE receptor antagonists with prolonged plasma lifetimes that are converted to active metabolites in vivo in monkeys.
Ye Q; Chourey S; Reddy CN; Wang R; Cossette C; Gravel S; Slobodchikova I; Vuckovic D; Rokach J; Powell WS
Br J Pharmacol; 2020 Jan; 177(2):388-401. PubMed ID: 31655025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
